University of Texas/Texas AM Investment Management Co (UTIMCO)’s Rein Therapeutics RNTX Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio RNTX Stock Details RNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$532K	Hold	511,610	–	–	0.06%	114
2026 Q1	$665K	Hold	511,610	–	–	0.1%	104
2025 Q4	$593K	Hold	511,610	–	–	0.08%	115
2025 Q3	$586K	Hold	511,610	–	–	0.08%	96
2025 Q2	$716K	Hold	511,610	–	–	0.11%	74
2025 Q1	$906K	Sell	511,610 -105,511	-17%	-$221K	0.16%	69
2024 Q4	$1.42M	Sell	617,121 -786,218	-56%	-$2.38M	0.17%	65
2024 Q3	$4.97M	Sell	1,403,339 -374,488	-21%	-$1M	0.81%	32
2024 Q2	$4.92M	Buy	+1,777,827	New	+$7.31M	0.96%	20

Other funds holding RNTX

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EAM

Empery Asset Management New York $86.5M AUM

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.87B AUM 24.49% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

RCG

Rock Creek Group Washington, District of Columbia $994M AUM 11.29% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s RNTX Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) held its Rein Therapeutics (RNTX) position steady in Q2 2026 at 511,610 shares worth $532K. The position accounts for 0.06% of the portfolio, ranked #114.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in RNTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.97M in Q3 2024. 26 funds tracked by Wall St. Rank hold RNTX as of Q2 2026.

University of Texas/Texas AM Investment Management Co (UTIMCO) held 511,610 shares of Rein Therapeutics worth $532K as of Q2 2026.
University of Texas/Texas AM Investment Management Co (UTIMCO) left its Rein Therapeutics share count unchanged in Q2 2026.
Rein Therapeutics made up 0.06% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #114 holding.
University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Rein Therapeutics in Q2 2024 and has held it in 9 quarters since.
University of Texas/Texas AM Investment Management Co (UTIMCO)'s Rein Therapeutics position peaked at $4.97M in Q3 2024.
26 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.